Polycystic ovary syndrome (PCOS) represents the most common endocrine dysfunction in
fertile women and it is considered a heterogeneous and multifaceted disorder, with multiple …

Metformin is an insulin sensitizer widely used for the treatment of patients affected by type 2
diabetes mellitus. Because many women with polycystic ovary syndrome (PCOS) are insulin …

Polycystic ovary syndrome (PCOS) is now recognized to be the most common
endocrinopathy in women of reproductive age with a prevalence of 6.6–6.8%. PCOS, a …

Polycystic ovary syndrome is the most common endocrinological disorder affecting 4-12% of
women and also the most controversial. Metformin was logically introduced to establish the …

BACKGROUND The extremes of BMI are associated with an increased risk of miscarriage
both in spontaneously conceived pregnancies and after fertility treatment. The aim of the …

With the exception of aspirin and heparin for the prevention of recurrent miscarriage in
women with the antiphospholipid syndrome, no other suggested therapies for this …

In normal human placentation, uterine invasion by trophoblast cells and subsequent spiral
artery remodeling depend on cooperation among fetal trophoblasts and maternal decidual …

Polycystic Ovary Syndrome (PCOS) is one of the common endocrine diseases that affects
women in their reproductive age. PCOS has diverse clinical implications that include …

OBJECTIVE: To evaluate the effect of pregestational metformin administration on abortion
risk in polycystic ovary syndrome (PCOS) patients. DESIGN: Systematic review and meta …

Objective. Patients with more than two spontaneous pregnancy losses are diagnosed with
recurrent pregnancy loss. The aim of this study was to evaluate the IR (insulin resistance) in …